Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 383 results found. Search for [ Coronavirus medicines ]

Results 1 to 21 of 383
Joe C Mathew
November 24, 2020
In an open letter to Prime Minister Narendra Modi on November 24, the civil society representatives said the current incidence, prevalence, and fatality status of COVID-19 disease in India, do not call for such an approach


BusinessToday.In
November 24, 2020
The researchers said they could not explicate why the half dose manifested better protection, but added it may be that it prompts the immune system differently


Joe C Mathew
November 21, 2020
The government has amended the Indian Medicine Central Council Regulations, 2016, to introduce formal training in these procedures as part of the curriculum for postgraduate students of shalya (general surgery) and shalakya (diseases of ear, nose, throat, ENT, eye, head, oro-dentistry) specialisations


Shailendra Shukla
New Delhi, November 21, 2020
WHO removes Remdesivir from list of COVID-19 medicines The World Health Organization said on Friday it has suspended Gilead's remdesivir from its so-called prequalification list, an official list of medicines used as a benchmark for procurement by developing countries, after issuing guidance against its use in hospitalised Covid-19 patients. \"The suspension is a signal to countries that WHO, in compliance with the treatment guidelines, does not recommend countries procure the drug for Covi...


Reuters
November 20, 2020
WHO suspended Gilead's remdesivir from its so-called prequalification list, an official list of medicines used as a benchmark for procurement by developing countries, after issuing guidance against its use in hospitalised Covid-19 patients


Reuters
November 20, 2020
The advice is another setback for the drug, which grabbed worldwide attention as a potentially effective treatment for COVID-19 in the summer after early trials showed some promise


Associated Press
November 20, 2020
The European commission has sealed deals with several pharmaceutical companies including BioNTech and Pfizer to buy millions of doses of vaccines on behalf of all EU Member States


PTI
November 15, 2020
Saudi Arabia's Ambassador to India Saud bin Mohammed Al Sati said the virtual summit on November 21-22 will largely focus on addressing the implications of the coronavirus pandemic and future health care plans


PTI
November 13, 2020
WHO Director General Tedros Adhanom Ghebreyesus made the announcement in a video message at an event in which Prime Minister Modi dedicated two future-ready Ayurveda institutions in Jaipur and Jamnagar to the nation


Reuters
November 11, 2020
Scientists, public health officials and investors welcomed the first successful interim data from a large-scale clinical test as a watershed moment that could help turn the tide of the pandemic if the full trial results pan out


BusinessToday.In
November 10, 2020
PM Modi on Tuesday addressed the annual summit of the SCO via video-conferencing. The prime minister called for \"reformed multilateralism\" that reflects the global realities of the present times


BusinessToday.In
November 7, 2020
Recently, Indian pharma companies are witnessing rampant cyber threats as they are delivering affordable medicines on a large scale amid the coronavirus pandemic


BusinessToday.In
November 3, 2020
German biotech firm CureVac has revealed its vaccine candidate has triggered an immune response during its phase 1 trials. The UK government has also started the process of the rolling review of AstraZeneca's candidate


Reuters
November 1, 2020
Johnson, at a hastily convened news conference in Downing Street after news of a lockdown leaked to local media, said that the one-month lockdown across England would kick in at a minute past midnight on Thursday morning and last until Dec. 2


BusinessToday.In
October 21, 2020
AstraZeneca's large, late-stage U.S. trial has been on hold since Sept. 6, after a participant in the company's UK trial fell ill


BusinessToday.In
New Delhi, October 20, 2020
Prime Minister Narendra Modi addressed the inaugural function of Grand Challenges Annual Meeting 2020, virtually via video conferencing. PM Modi said that the country was witnessing a decline in the number of coronavirus cases per day and its growth rate. He said that the country is at the forefront of COVID vaccine development and is working on putting a well-established vaccine delivery system in place. Talking about the vaccine industry in India, Modi added that the country is known for its proven capacity to produce quality vaccines and medicines at low cost. Watch the video for more.Also Read: PM Modi Speech Highlights: No leniency till we get a vaccine, says PM


BusinessToday.In
October 20, 2020
Bill Gates says India's research and manufacturing will be critical to fighting Covid-19 especially when it comes to making vaccines at large scale; adds that vaccine development alone won't address problem as its production can throw various challenges


Joe C Mathew
October 18, 2020
The sponsoring member nations argued that the absence of a waiver, existing protection for intellectual property (IP) rights may curtail non-IP holders from accessing knowledge and technology needed to scale up research


PTI
October 17, 2020
Modi insisted on continued social distancing and COVID-appropriate behaviour such as wearing masks, regularly washing hands and sanitation, especially during upcoming festival season


BusinessToday.In
October 16, 2020
In these tightly-controlled trials, volunteers will be given a vaccine and then about a month later they will deliberately be infected with COVID-19 under controlled conditions


PAGES 1 OF 20  12345